Publishing research using ab40278? Please let us know so that we can cite the reference in this datasheet.

ab40278 has been referenced in 9 publications.

  • Kim JH  et al. RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation. Oncogenesis 3:e101 (2014). PubMed: 24777122
  • Yu F  et al. RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma. Oncogene 33:2601-9 (2014). Human . PubMed: 23851507
  • Tanaka S  et al. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma. Int J Cancer 131:2537-46 (2012). WB ; Human . PubMed: 22488108
  • Fu Y  et al. RUNX3 Maintains the Mesenchymal Phenotype after Termination of the Notch Signal. J Biol Chem 286:11803-13 (2011). WB ; Human . PubMed: 21288908
  • Goh YM  et al. Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm. J Biol Chem 285:10122-9 (2010). WB ; Human . PubMed: 20100835
  • Kodach LL  et al. The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer. Carcinogenesis 31:1567-75 (2010). WB ; Human . PubMed: 20631058
  • Sakakura C  et al. Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis. Oncogene 26:5927-38 (2007). WB ; Human . PubMed: 17384682
  • Yano T  et al. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Mol Cell Biol 26:4474-88 (2006). PubMed: 16738314
  • Salto-Tellez M  et al. RUNX3 protein is overexpressed in human basal cell carcinomas. Oncogene 25:7646-9 (2006). WB ; Human . PubMed: 16767156

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"